當前位置: 首頁 SCI期刊 SCIE期刊 醫學 中科院1區 JCRQ1 期刊介紹(非官網)
        Cell Reports Medicine

        Cell Reports MedicineSCIE

        國際簡稱:Cell Rep Med  參考譯名:細胞醫學報道

        • 中科院分區

          1區

        • CiteScore分區

          Q1

        • JCR分區

          Q1

        基本信息:
        ISSN:2666-3791
        E-ISSN:2666-3791
        是否OA:開放
        是否預警:否
        TOP期刊:是
        出版信息:
        出版地區:United States
        出版商:Elsevier
        出版語言:English
        出版周期:Monthly
        出版年份:2020
        研究方向:Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
        評價信息:
        影響因子:11.7
        CiteScore指數:15
        SJR指數:4.276
        SNIP指數:1.664
        發文數據:
        Gold OA文章占比:93.57%
        研究類文章占比:95.74%
        年發文量:305
        自引率:0.0139...
        開源占比:0.8876
        出版撤稿占比:
        出版國人文章占比:0
        OA被引用占比:
        英文簡介 期刊介紹 CiteScore數據 中科院SCI分區 JCR分區 發文數據 常見問題

        英文簡介Cell Reports Medicine期刊介紹

        Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

        The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

        Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

        The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

        期刊簡介Cell Reports Medicine期刊介紹

        《Cell Reports Medicine》自2020出版以來,是一本醫學優秀雜志。致力于發表原創科學研究結果,并為醫學各個領域的原創研究提供一個展示平臺,以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述,從廣泛的視角提供當前感興趣的研究主題的新見解,或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單,目前已被權威數據庫SCIE收錄,得到了廣泛的認可。

        該期刊投稿重要關注點:

        • 預計審稿時間:約Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks
        • 國際TOP期刊
        • 醫學
        • MEDICINE, RESEARCH & EXPERIMENTAL
        • SCIE
        • 中科院1區
        • 非預警

        Cite Score數據(2024年最新版)Cell Reports Medicine Cite Score數據

        • CiteScore:15
        • SJR:4.276
        • SNIP:1.664
        學科類別 分區 排名 百分位
        大類:Medicine 小類:General Medicine Q1 25 / 636

        96%

        大類:Medicine 小類:General Biochemistry, Genetics and Molecular Biology Q1 18 / 221

        92%

        CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎,針對的是前四年發表的論文的引文。CiteScore的意義在于,它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法,而不僅僅是通過影響因子(IF)這一單一指標來評價。

        歷年Cite Score趨勢圖

        中科院SCI分區Cell Reports Medicine 中科院分區

        中科院 2023年12月升級版 綜述期刊:否 Top期刊:是
        大類學科 分區 小類學科 分區
        醫學 1區 MEDICINE, RESEARCH & EXPERIMENTAL 醫學:研究與實驗 CELL BIOLOGY 細胞生物學 1區 2區

        中科院分區表 是以客觀數據為基礎,運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據,得到了全國各地高校、科研機構的廣泛認可。

        中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次,類似于“優、良、及格”等。最開始,這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

        歷年中科院分區趨勢圖

        JCR分區Cell Reports Medicine JCR分區

        2023-2024 年最新版
        按JIF指標學科分區 收錄子集 分區 排名 百分位
        學科:CELL BIOLOGY SCIE Q1 22 / 205

        89.5%

        學科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 10 / 189

        95%

        按JCI指標學科分區 收錄子集 分區 排名 百分位
        學科:CELL BIOLOGY SCIE Q1 14 / 205

        93.41%

        學科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 8 / 189

        96.03%

        JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異,此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此,JCR將期刊按照學科門類和影響因子分為不同的分區,這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

        歷年影響因子趨勢圖

        本刊中國學者近年發表論文

        • 1、Current understanding of the intratumoral microbiome in various tumors

          Author: Xue, Chen; Chu, Qingfei; Zheng, Qiuxian; Yuan, Xin; Su, Yuanshuai; Bao, Zhengyi; Lu, Juan; Li, Lanjuan

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100884

        • 2、Inherited mutations in Chinese patients with upper tract urothelial carcinoma

          Author: Wu, Junlong; Jin, Shengming; Gu, Chengyuan; Wei, Yu; Zhu, Yao; Necchi, Andrea; Shariat, Shahrokh F.; Pan, Jian; Gan, Hualei; Dai, Bo; Zhang, Hailiang; Shi, Guohai; Zhu, Yu; Shen, Yijun; Zhu, Yiping; Ye, Dingwei

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100883

        • 3、Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases

          Author: Guo, Jiawei; Wang, Fuxiao; Hu, Yan; Luo, Ying; Wei, Yan; Xu, Ke; Zhang, Hao; Liu, Han; Bo, Lumin; Lv, Shunli; Sheng, Shihao; Zhuang, Xinchen; Zhang, Tao; Xu, Can; Chen, Xiao; Su, Jiacan

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100881

        • 4、Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET

          Author: Zhang, Qilin; Yao, Boyuan; Long, Xin; Chen, Zhengyuan; He, Min; Wu, Yue; Qiao, Nidan; Ma, Zengyi; Ye, Zhao; Zhang, Yichao; Yao, Shun; Wang, Ye; Cheng, Haixia; Chen, Hong; Ye, Hongying; Wang, Yongfei; Li, Yimin; Chen, Jianhua; Zhang, Zhaoyun; Guo, Fan; Zhao, Yao

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100934

        • 5、Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

          Author: Wang, Han-Min; Zhang, Chan-Yuan; Peng, Kai-Cheng; Chen, Ze-Xin; Su, Jun-Wei; Li, Yu-Fa; Li, Wen-Feng; Gao, Qing-Yun; Zhang, Shi-Ling; Chen, Yu-Qing; Zhou, Qing; Xu, Cong; Xu, Chong-Rui; Wang, Zhen; Su, Jian; Yan, Hong-Hong; Zhang, Xu-Chao; Chen, Hua-Jun; Wu, Yi-Long; Yang, Jin-Ji

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100911

        • 6、Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma

          Author: Tian, Xiao-Peng; Zhang, Yu-Chen; Lin, Ning-Jing; Wang, Liang; Li, Zhi-Hua; Guo, Han-Guo; Ma, Shu-Yun; An, Ming-Jie; Yang, Jing; Hong, Yu-Heng; Wang, Xian-Huo; Zhou, Hui; Li, Ya-Jun; Rao, Hui-Lan; Li, Mei; Hu, Shao-Xuan; Lin, Tong-Yu; Li, Zhi-Ming; Huang, He; Liang, Yang; Xia, Zhong-Jun; Lv, Yue; Liu, Yu-Ying; Duan, Zhao-Hui; Chen, Qing-Yu; Wang, Jin-Ni; Cai, Jun; Xie, Ying; Ong, Choon-Kiat; Liu, Fang; Liu, Yan-yan; Yan, Zheng; Huang, Liang; Tao, Rong; Li, Wen-Yu; Huang, Hui-Qiang; Cai, Qing-Qing

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100859

        • 7、Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer

          Author: Tang, Zhaoqing; Gu, Yuan; Shi, Zhongyi; Min, Lingqiang; Zhang, Ziwei; Zhou, Peng; Luo, Rongkui; Wang, Yan; Cui, Yuehong; Sun, Yihong; Wang, Xuefei

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100931

        • 8、DeepFundus: A flow-cytometry-like image quality classifier for boosting the whole life cycle of medical artificial intelligence

          Author: Liu, Lixue; Wu, Xiaohang; Lin, Duoru; Zhao, Lanqin; Li, Mingyuan; Yun, Dongyuan; Lin, Zhenzhe; Pang, Jianyu; Li, Longhui; Wu, Yuxuan; Lai, Weiyi; Xiao, Wei; Shang, Yuanjun; Feng, Weibo; Tan, Xiao; Li, Qiang; Liu, Shenzhen; Lin, Xinxin; Sun, Jiaxin; Zhao, Yiqi; Yang, Ximei; Ye, Qinying; Zhong, Yuesi; Huang, Xi; He, Yuan; Fu, Ziwei; Xiang, Yi; Zhang, Li; Zhao, Mingwei; Qu, Jinfeng; Xu, Fan; Lu, Peng; Li, Jianqiao; Xu, Fabao; Wei, Wenbin; Dong, Li; Dai, Guangzheng; He, Xingru; Yan, Wentao; Zhu, Qiaolin; Lu, Linna; Zhang, Jiaying; Zhou, Wei; Meng, Xiangda; Li, Shiying; Shen, Mei; Jiang, Qin; Chen, Nan; Zhou, Xingtao; Li, Meiyan; Wang, Yan; Zou, Haohan; Zhong, Hua; Yang, Wenyan; Shou, Wulin; Zhong, Xingwu; Yang, Zhenduo; Ding, Lin; Hu, Yongcheng; Tan, Gang; He, Wanji; Zhao, Xin; Chen, Yuzhong; Liu, Yizhi; Lin, Haotian

          Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100912

        投稿常見問題

        通訊方式:ELSEVIER, RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX。

        主站蜘蛛池模板: 福利一区二区视频| 中文字幕在线看视频一区二区三区| 国产福利一区二区三区| 日本精品视频一区二区| 无码人妻精品一区二区| 日韩精品一区二区三区中文3d | 无码AV中文一区二区三区| 日本一区二区三区在线视频| 国产主播在线一区| 亚洲午夜福利AV一区二区无码| 亚洲熟妇无码一区二区三区| 亚洲AV色香蕉一区二区| 日韩人妻无码一区二区三区综合部| 久久一区二区三区精华液使用方法| 国产精品福利区一区二区三区四区| 日本免费一区尤物| 成人免费视频一区| 精品深夜AV无码一区二区老年| 色噜噜狠狠一区二区三区果冻 | 日本一区二区在线播放| 国产综合精品一区二区三区| 伊人久久精品无码av一区| 国产亚洲一区区二区在线| 亚洲AV日韩AV天堂一区二区三区| 日韩免费观看一区| 欧亚精品一区三区免费| 国产精品资源一区二区| 亚洲视频一区二区| 亚洲一区影音先锋色资源| 99久久人妻精品免费一区| 久久人妻无码一区二区| 国产在线观看一区精品| 欧洲无码一区二区三区在线观看| 日本激情一区二区三区| 精品日韩一区二区三区视频| 人妻无码一区二区三区四区| 国产亚洲3p无码一区二区| 国产精品成人免费一区二区 | 中文字幕一区二区三| 竹菊影视欧美日韩一区二区三区四区五区 | 精品无码人妻一区二区三区不卡|